Yahoo Web Search

Search results

    • AbbVie makes oncology progress with two drug trials

      Crain s Chicago Business· 20 hours ago

      Multiple myeloma, the second-most common blood cancer, is characterized by abnormal proliferation of plasma cells, which can cause end-organ damage, AbbVie said in a statement ...

    • How to Cope With the Financial Toll of Cancer

      How to Cope With the Financial Toll of Cancer

      Time via Yahoo Finance· 4 days ago

      Affording their cancer medications should be the last thing those patients should be worried about,” Klein says. Financial hardship is associated with...